Experimental antibody therapies for Parkinson’s and Alzheimer’s may cause harmful inflammation

Image

Scientists find evidence that antibody-based treatments in clinical trials for neurodegenerative diseases may trigger an inflammatory response in human brain immune cells, eroding their positive effects.